Osang Healthcare Co.,Ltd (KOSDAQ:036220)
6,750.00
-100.00 (-1.46%)
At close: Jun 5, 2026
Osang Healthcare Co.,Ltd Revenue
Osang Healthcare Co.,Ltd had revenue of 22.88B KRW in the quarter ending March 31, 2026, a decrease of -28.80%. This brings the company's revenue in the last twelve months to 119.38B, up 29.85% year-over-year. In the year 2025, Osang Healthcare Co.,Ltd had annual revenue of 128.63B with 59.81% growth.
Revenue (ttm)
119.38B
Revenue Growth
+29.85%
P/S Ratio
0.77
Revenue / Employee
359.57M
Employees
332
Market Cap
91.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 128.63B | 48.14B | 59.81% |
| Dec 31, 2024 | 80.49B | -275.36B | -77.38% |
| Dec 31, 2023 | 355.85B | 161.95B | 83.53% |
| Dec 31, 2022 | 193.89B | 61.57B | 46.53% |
| Dec 31, 2021 | 132.33B | -125.64B | -48.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 122.78B |
| Ray Co., Ltd. | 112.53B |
| Bio Plus | 94.42B |
| LabGenomics | 84.19B |
| T&R Biofab | 29.73B |
| HASS Corp. | 16.58B |
| Sugentech | 9.87B |
| P&S Robotics | 8.55B |